Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Rosethorne EM"'
Autor:
Rosethorne EM, Charlton SJ
Publikováno v:
Journal of Experimental Pharmacology, Vol Volume 10, Pp 75-85 (2018)
Elizabeth M Rosethorne,1–3 Steven J Charlton1–3 1School of Life Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK; 2Centre of Membrane and Protein and Receptors (COMPARE), University of Birmingham and University
Externí odkaz:
https://doaj.org/article/2b0b20e1d3014f81b76857bb62458b93
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Addis P; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Bali U; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Baron F; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Campbell A; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Harborne S; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Jagger L; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Milne G; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Pearce M; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Rosethorne EM; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Satchell R; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Swift D; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Young B; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK., Unitt JF; Bioscience, Medicinal Chemistry, Pharmacology and Protein Science Departments, Sygnature Discovery Ltd, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK. Electronic address: j.unitt@sygnaturediscovery.com.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2024 Jan; Vol. 29 (1), pp. 1-22. Date of Electronic Publication: 2023 Aug 23.
Autor:
Roberts MJ; Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., May LT; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., Keen AC; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., Liu B; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., Lam T; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia., Charlton SJ; Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.; Excellerate Bioscience Ltd., BioCity, Nottingham, United Kingdom., Rosethorne EM; Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom., Halls ML; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Apr 29; Vol. 12, pp. 669227. Date of Electronic Publication: 2021 Apr 29 (Print Publication: 2021).
Autor:
Bradley SJ; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. sophie.bradley@glasgow.ac.uk., Molloy C; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Valuskova P; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Dwomoh L; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Scarpa M; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Rossi M; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Finlayson L; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Svensson KA; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Chernet E; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Barth VN; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Gherbi K; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Excellerate Bioscience Ltd, BioCity, Nottingham, UK., Sykes DA; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Centre of Membrane and Protein and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK., Wilson CA; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Mistry R; Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester, UK., Sexton PM; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia., Christopoulos A; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia., Mogg AJ; Eli Lilly & Co, Neuroscience Discovery, Lilly Corporate Center, Indianapolis, IN, USA., Rosethorne EM; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Centre of Membrane and Protein and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK., Sakata S; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., John Challiss RA; Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester, UK., Broad LM; Eli Lilly & Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, UK., Tobin AB; The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. andrew.tobin@glasgow.ac.uk.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2020 Mar; Vol. 16 (3), pp. 240-249. Date of Electronic Publication: 2020 Feb 20.
Autor:
Roberts MJ; School of Life Sciences, University of Nottingham, Nottingham, UK., Broome RE; Novartis Institutes for Biomedical Research, Horsham, UK., Kent TC; Novartis Institutes for Biomedical Research, Horsham, UK., Charlton SJ; School of Life Sciences, University of Nottingham, Nottingham, UK.; Novartis Institutes for Biomedical Research, Horsham, UK., Rosethorne EM; School of Life Sciences, University of Nottingham, Nottingham, UK. elizabeth.rosethorne@nottingham.ac.uk.; Novartis Institutes for Biomedical Research, Horsham, UK. elizabeth.rosethorne@nottingham.ac.uk.
Publikováno v:
Respiratory research [Respir Res] 2018 Apr 07; Vol. 19 (1), pp. 56. Date of Electronic Publication: 2018 Apr 07.
Autor:
Sattikar A; Novartis Institutes for Biomedical Research, Horsham, UK., Dowling MR; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Rosethorne EM; Novartis Institutes for Biomedical Research, Horsham, UK.; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2017 Feb; Vol. 174 (3), pp. 227-237. Date of Electronic Publication: 2017 Jan 06.
Autor:
Rosethorne EM; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Bradley ME; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Gherbi K; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Sykes DA; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Sattikar A; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Wright JD; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Renard E; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Trifilieff A; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Fairhurst RA; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.)., Charlton SJ; Novartis Institutes for Biomedical Research, Horsham, West Sussex, United Kingdom (E.M.R., M.E.B., K.G., D.A.S., A.S., J.D.W., S.J.C.); Novartis Institutes for Biomedical Research, Basel, Switzerland (E.R., A.T., R.A.F.); and School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom (E.M.R., K.G., D.A.S., S.J.C.) Steven.Charlton@nottingham.ac.uk.
Publikováno v:
Molecular pharmacology [Mol Pharmacol] 2016 Apr; Vol. 89 (4), pp. 467-75. Date of Electronic Publication: 2016 Jan 15.